Profile: NeuroRevolution, Inc. is a preclinical contract research organization (CRO) dedicated to the evaluation of new drugs and targets for neuropsychiatric disorders & related research programs. We provide preclinical neuropsychiatric testing of compounds and transgenic mice. We offer a complete set of behavioral and pharmacological assays for major CNS disorders, including behavioral toxicology that is required in FDA filings for all compounds. Our services cover the fields such as surgery, microdialysis, electrophysiology, EEG (in mouse), ABR, ERG, anatomy, histology, pathology, bio/neurochemistry, custom assay, and protocol design, consulting and training.